| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |